Bharat Biotech has completed the Phase II/III clinical trials of Covaxin on children in the 2-18 years age group and is all set to submit the data to the Drugs Controller General of India (DCGI), the company’s chairman & managing director Dr Krishna Ella said on Tuesday.from Hyderabad News: Latest Hyderabad News Headlines & Live News Updates from Hyderabad - Times of India https://ift.tt/3hWtYDN
No comments:
Post a Comment